It was finally proven that KIF22 can participate in the cycle regulation of pancreatic cancer cells via the MEK/ERK/P21 signaling axis, thereby promoting the occurrence and progression of pancreatic cancer. Here, CDKN1A is linked to familial pancreatic carcinoma.